EUVIMEDEUVIMED entdecken
Open Access

Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

April Jorge iD, Na Lu, Hyon Choi, John M Esdaile, Diane Lacaille iD, J Antonio Avina-Zubieta iD

Arthritis Care & Research · 2023-04 · 75 (4) · 743-748

DOI: 10.1002/acr.24850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 17.12.2022. Verfasst von April Jorge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Antirheumatic Agents, Venous Thromboembolism, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, Canadian Institutes of Health Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We evaluated the potential temporal association between hydroxychloroquine (HCQ) use and cardiovascular (CV) events among patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA).

Methods

We conducted a nested case–control study within inception cohorts of SLE and RA patients using administrative health databases including the entire population of British Columbia, Canada. We identified cases with incident CV events, including myocardial infarction (MI), stroke, or venous thromboembolism (VTE). We matched each case with up to 3 controls on age, sex, and rheumatic disease. HCQ exposure was categorized by the time between the last HCQ prescription date covered and the index date as current use, recent use, remote use, or never used. We used conditional logistic regression to assess the association between HCQ exposure and CV events, using remote use as the reference group.

Results

We identified 10,268 cases and 29,969 controls. Adjusted conditional odd ratios (cORs) and 95% confidence intervals (95% CIs) for current HCQ use relative to remote use were 0.86 (0.77–0.97) for combined CV events, 0.88 (0.74–1.05) for MI, 0.87 (0.74–1.03) for stroke, and 0.74 (0.59–0.94) for VTE. Recent HCQ users and nonusers had similar odds of combined CV events as remote users (cORs 0.93, 95% CI 0.77–1.13 and 0.96, 95% CI 0.88–1.04, respectively).

Conclusion

In this nested case–control study of patients with SLE and RA, we found a reduced risk of overall CV events associated with current HCQ use, including reductions in VTE and trends toward reductions in MI and stroke. These findings suggest a possible cardiovascular preventative benefit of HCQ use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsVenous ThromboembolismLupus Erythematosus, SystemicArthritis, RheumatoidMyocardial InfarctionStrokeHumansHydroxychloroquineCase-Control StudiesBritish Columbia

Substanzen

HydroxychloroquineAntirheumatic Agents

Autor:innen und Institutionen

  • Massachusetts General Hospital, Boston.
  • Massachusetts General Hospital, Boston, and Arthritis Research Canada, Richmond, British Columbia, Canada.
  • Arthritis Research Canada and University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: April Jorge, Diane Lacaille, J Antonio Avina-Zubieta

Förderung

  • NIAMS NIH HHS
  • Canadian Institutes of Health Research
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Rheumatology Research Foundation

Zitieren

APA

Jorge, A., Lu, N., Choi, H., Esdaile, J. M., Lacaille, D., & Avina-Zubieta, J. A. (2023). Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. Arthritis Care & Research, 75(4), 743-748. https://doi.org/10.1002/acr.24850

Vancouver

Jorge A, Lu N, Choi H, Esdaile JM, Lacaille D, Avina-Zubieta JA. Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis. Arthritis Care & Research. 2023;75(4):743-748. doi:10.1002/acr.24850

BibTeX
@article{Jorge2023,
  author = {Jorge, April and Lu, Na and Choi, Hyon and Esdaile, John M and Lacaille, Diane and Avina-Zubieta, J Antonio},
  title = {Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis},
  journal = {Arthritis Care & Research},
  year = {2023},
  volume = {75},
  number = {4},
  pages = {743--748},
  doi = {10.1002/acr.24850}
}
Kostenlos starten →